Define a “rare disorder” and Implement a national drug policy
This petition made change with 647 supporters!
We request the House of Commons Define a “rare disorder” as a life-threatening or chronically debilitating condition or disease with a prevalence in Canada of fewer than one in 2,000 people.
Implement a national drug policy in regard to the treatment of rare disorders
• Canadian patients who suffer from rare disorders lack access to clinical trials and new drugs that are available in other countries
• it is essential to ensure that all patients have equal and timely access to therapies for life-threatening and debilitating diseases
• continuing research investment by Canadians in genomics, proteomics, cell therapy and regenerative medicine will lead to the development of new therapies for rare disorders
• it is reasonable to assume that many new therapies for rare disorders will not be brought to market due to the low number of patients relative to the high cost of development
• Canada is one of few developed countries to lack a definition for rare disorders
• policies enacted in other countries to encourage the development of treatment of rare disorders have enabled the development of new treatments for patients
• Canadians would enjoy enhanced health and economic benefits if incentives were provided to assist Canadian innovators in developing and marketing drugs for use in the treatment of rare disorders.
Today: Canadian is counting on you
Canadian Organization for Rare Disorders needs your help with “Canadian House of Commons: Define a “rare disorder” and Implement a national drug policy”. Join Canadian and 646 supporters today.